Supply Chain/Technology

Latest Issue of OR Manager
June 2018
Home Supply Chain/Technology

FDA: Premier Pharmacy Labs recalls certain sterile injectable products

Editor's Note The Food and Drug Administration (FDA) on April 12 announced the recall by Premier Pharmacy Labs (Weeki Wachee, Florida) of certain lots of sterile injectable products because of a potential lack of sterility assurance. The products include morphine sulfate (2 mg/mL and 3 mg/mL), hydromorphone HCL 1 mg/mL,…

Read More

By: Judy Mathias
April 16, 2018
Share

FDA: Recall of Acrodose Plus and PL systems by Haemonetics

Editor's Note The Food and Drug Administration (FDA) on April 13 announced the recall by Haemonetics (Braintree, Massachusetts) of certain lots of its Acrodose Plus and PL Systems because the company has received reports of low pH readings for platelets stored in CLX HP bags. In some instances the drop…

Read More

By: Judy Mathias
April 13, 2018
Share

ECRI Institute announces new Culture of Safety Assessment for Health IT Companies

Editor's Note The ECRI Institute and the Partnership for Health IT Patient Safety (ie, a multistakeholder collaborative convened and operated by the ECRI Institute) announced April 10 the new INsight® Culture of Safety Assessment for Health IT Companies. The new program allows health IT developers to assess safety culture with…

Read More

By: Judy Mathias
April 11, 2018
Share

FDA announces AccessGUDID data update

Editor's Note The Food and Drug Administration announced that new data elements will be available on AccessGUDID, in the download files and in the APIs, as of April 2. Data for FDA Premarket Submission Number and FDA Premarket Supplement Number will not be provided until this summer. The FDA is…

Read More

By: Judy Mathias
April 9, 2018
Share

EHRs hinder ability to report quality measures

Editor's Note The poor design of electronic health records (EHRs) poses challenges for primary care practices to generate the required reports for federal value-based payment programs, this study finds. An analysis of survey responses from 1,492 practices in 12 states, found that the reports generated for meaningful-use participation, which requires…

Read More

By: Judy Mathias
April 6, 2018
Share

ECRI Institute issues free white paper on purchased services best practices

Editor's note The ECRI Institute on April 2 issued a free white paper on “5 Ways to Drive Savings and Quality on Your Purchased Services.” The 5 key areas to consider when developing a best practice process to evaluate purchased services, reduce spending, and make informed vendor selections are: Making…

Read More

By: Judy Mathias
April 3, 2018
Share

FDA: Class I recall of BD Vacutainer blood collection tubes

Author's Note The Food & Drug Administration on March 23 announced the Class I recall of Becton Dickinson (BD) Vacutainer EDTA (ethylenediaminetetraacetic acid) blood collection tubes with lavender, tan, pink, and green rubber tube stoppers. Class I recalls are the most serious. The recall was initiated because of a chemical…

Read More

By: Judy Mathias
April 2, 2018
Share

FDA: Recall of methylprednisolone sodium succinate for injection

Editor's Note The Food and Drug Administration (FDA) on March 6 announced the recall by Sagent Pharmaceuticals (Schaumburg, Illinois) of 10 lots of methylprednisolone sodium succinate for injection, USP, 40 mg, 125 mg, and 1 g. The recall was initiated because of the discovery of high out of specification impurity…

Read More

By: Judy Mathias
March 7, 2018
Share

Analysis predicts growth for thoracolumbar spine devices market

Editor's Note A Technavio analysis predicts that the global market for thoracolumbar spine devices will see a compound annual growth rate of almost 4% through 2022, the March 1 Becker’s SpineReview reports. A major driver of the growth is the increasing prevalence of spinal disorders. The market was dominated in…

Read More

By: Judy Mathias
March 7, 2018
Share

Global orthopedics market set to grow

Editor's Note A GlobalData analysis predicts the global orthopedics market will reach $66.2 billion by 2023, with a compound annual growth rate of 3.8%, the March 2 Becker’s SpineReview reports. Among the key players in the market, which is dominated by spine devices, hip and knee implants, and trauma fixation…

Read More

By: Judy Mathias
March 6, 2018
Share
Live chat by BoldChat